Mark Dow, Ph.D.

Mark P.D. Dow, Ph.D.

Headshot of Mark Dow
  • REI Laboratory Director: Johns Hopkins Fertility Center
  • Assistant Professor of Gynecology and Obstetrics

Background

Mark Dow is the laboratory director of the Division of Reproductive Endocrinology and Infertility and Assistant Professor of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine. His areas of expertise include clinical andrology and in vitro fertilization.

Dr. Dow received his Bachelor of Science degree in biochemistry from the University of Wisconsin-Madison and his Doctor or Philosophy degree from Michigan State University in Reproductive Physiology.

Dr. Dow has been serving infertility patients for over 30 years and plays an active role in the American Society of Reproductive Medicine, College of Reproductive Biology, and the Society of Assisted Reproductive Technology.

...read more

Titles

  • REI Laboratory Director: Johns Hopkins Fertility Center
  • Laboratory Director, Division of Reproductive Endocrinology and Infertility
  • Assistant Professor of Gynecology and Obstetrics

Departments / Divisions

Education

Degrees

  • Ph.D.; Michigan State University (Michigan) (2002)
  • B.S.; University of Wisconsin (Madison) (Wisconsin) (1989)

Research & Publications

Research Summary

Dr. Dow’s current interest including streamlining and improving laboratory methods resulting in improved pregnancy outcomes and the patient experience of infertility patients.

Selected Publications

View all on PubMed

Dow MP, Jones JM, Dumesic DA, Lu Y, Shapiro SS. The successful use of hyperstimulated washed therapeutic donor insemination after standard therapeutic donor insemination has failed. Int J Fertil Menopausal Stud. 1996 Nov-Dec;41(6):516-21. PMID: 9010745

Dow MP, Bakke LJ, Cassar CA, Peters MW, Pursley JR, Smith GW. Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue. Biol Reprod. 2002 May;66(5):1413-21. doi: 10.1095/biolreprod66.5.1413. PMID: 11967205

Bakke LJ, Dow MP, Cassar CA, Peters MW, Pursley JR, Smith GW. Effect of the preovulatory gonadotropin surge on matrix metalloproteinase (MMP)-14, MMP-2, and tissue inhibitor of metalloproteinases-2 expression within bovine periovulatory follicular and luteal tissue. Biol Reprod. 2002 Jun;66(6):1627-34. doi: 10.1095/biolreprod66.6.1627. PMID: 12021040

Smith MF, Ricke WA, Bakke LJ, Dow MP, Smith GW. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors. Mol Cell Endocrinol. 2002 May 31;191(1):45-56. doi: 10.1016/s0303-7207(02)00054-0. PMID: 12044918.

Bakke LJ, Li Q, Cassar CA, Dow MP, Pursley JR, Smith GW. Gonadotropin surge-induced differential upregulation of collagenase-1 (MMP-1) and collagenase-3 (MMP-13) mRNA and protein in bovine preovulatory follicles. Biol Reprod. 2004 Aug;71(2):605-12. doi: 10.1095/biolreprod.104.027185. Epub 2004 Apr 28. PMID: 15115716

Activities & Honors

Honors

  • Reviewer, Fertility and Sterility, 1981
  • Journal of Assisted Reproduction & Genetics 1982, 1982

Memberships

  • American Society of Reproductive Medicine
  • Society for Assisted Reproduction Technology
  • College of Reproductive Biology

Professional Activities

  • Lab Director, Society for Assisted Reproductive Technology (SART), 2010 - 2012
  • Member, American Society for Reproductive Medicine 01/1992-Present, 1992 - 2021
  • Membership Committee, American Society for Reproductive Medicine, 2016 - 2021
  • Membership Committee10/2016-10/2021, Society of Reproductive Biologists and Technologist Society, 2016 - 2021
  • Executive Board Member, Reproductive Laboratory Technology Professional Group, 2006 - 2011
  • Executive Board Member, American Board of Bioanalysts for the College of Reproductive Biology, 2012 - 2014

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button